MARKET

TELO

TELO

Telomir Pharms
NASDAQ
1.250
+0.010
+0.81%
After Hours: 1.250 0 0.00% 16:10 06/29 EDT
OPEN
1.250
PREV CLOSE
1.240
HIGH
1.270
LOW
1.240
VOLUME
43.53K
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
1.050
MARKET CAP
85.97M
P/E (TTM)
-4.2633
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TELO last week (0622-0626)?
Weekly Report · 15h ago
Weekly Report: what happened at TELO last week (0615-0619)?
Weekly Report · 06/22 09:15
Telomir Showcases Preclinical Telomir-Zn Diabetes Efficacy Data
TipRanks · 06/15 12:37
Telomir Pharmaceuticals announces publication of data on Telomir-Zn
TipRanks · 06/15 12:34
Telomir Pharmaceuticals Publishes Peer-Reviewed Preclinical Data In Biomedicine & Pharmacotherapy Titled "Telomir-Zn Restores Glucose Homeostasis and Reduces Insulin Resistance in a Diet-Induced Zebrafish Model of Type 2 Diabetes"
Benzinga · 06/15 12:04
Telomir Pharmaceuticals reports Telomir-Zn restores insulin sensitivity in preclinical type 2 diabetes model study
PUBT · 06/15 12:01
Weekly Report: what happened at TELO last week (0608-0612)?
Weekly Report · 06/15 09:15
Telomir Pharmaceuticals CFO Andriy Mushak files initial beneficial ownership statement
PUBT · 06/09 21:01
More
About TELO
Telomir Pharmaceuticals, Inc. is a biotechnology company developing small-molecule therapeutics designed to target epigenetic and metabolic mechanisms implicated in cancer, aging, and degenerative disease. The Company's lead candidate, Telomir-1 (Telomir-Zn), is an investigational therapy that has demonstrated activity in preclinical studies involving modulation of intracellular metal homeostasis, epigenetic regulation, mitochondrial function, and genomic stability. Telomir-1 is an oral small molecule metal ion regulator designed to extend telomere caps, maintain cellular balance, and combat oxidative stress, a key driver of aging and disease progression. By modulating essential metal ions such as iron, and copper, Telomir-1 may help protect against age related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease, and Age-related Macular Degeneration (AMD), as well as Type 2 diabetes, breast cancer, and Alzheimer’s disease.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.